Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

University of Oxford to help tackle disease outbreaks anywhere in the world in 48 hours

General

The Public Health Minister Nicola Blackwood this week announced that the UK has a specialist team of health experts ready to be deployed to tackle outbreaks of deadly disease anywhere in the world within 48 hours.

Medics in protective hazzard suits

The UK Public Health Rapid Support Team (PHRST) will be on call to respond to urgent requests from countries around the world and fly in to help tackle disease outbreaks at source. The University of Oxford epidemic diseases research group, led by Professor Peter Horby, is providing the clinical research capabilities of the PHRST.

Professor Horby said: “Our epidemic diseases research group has unparalleled experience of conducting clinical research on major emerging and epidemic infectious diseases, from SARS and bird flu to Ebola. We are delighted to be part of this new team because it integrates public health and research, and it recognises the critical role of science in delivering rapid and reliable evidence to improve the care of patients and the control of outbreaks."

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.